Martin C Chang

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors
    Martin C Chang
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Children s Hospital Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 28:347-55. 2009
  2. ncbi Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival
    Martin C Chang
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 29:88-92. 2010
  3. ncbi The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls
    Karishma K Mehra
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Mod Pathol 24:152-6. 2011
  4. ncbi High-grade and low-grade pelvic serous neoplasms demonstrate differential p53 immunoreactivity in peritoneal washings
    Martin C Chang
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Acta Cytol 55:79-84. 2011

Collaborators

Detail Information

Publications4

  1. ncbi Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors
    Martin C Chang
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Children s Hospital Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 28:347-55. 2009
    ..The inclusion of these markers should therefore be considered in cases of pure or mixed ovarian germ cell tumors that are difficult to classify, and to exclude nongerm cell tumor mimics...
  2. ncbi Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival
    Martin C Chang
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 29:88-92. 2010
    ..Extensive, recurring AIS is a rare variant that may be unique for its risk of coincident ovarian involvement. However, ovarian spread, albeit rare, does not invariably result in an adverse outcome...
  3. ncbi The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls
    Karishma K Mehra
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Mod Pathol 24:152-6. 2011
    ..Attention to this detail is critical when exploring risk factors germane to early serous carcinogenesis...
  4. ncbi High-grade and low-grade pelvic serous neoplasms demonstrate differential p53 immunoreactivity in peritoneal washings
    Martin C Chang
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Acta Cytol 55:79-84. 2011
    ..The current study correlates p53 immunoreactivity in peritoneal washings with the cytologic interpretation and histology of the corresponding serous neoplasm...